BYDUREON

Details for Australian Trade Mark No. 1227014 (hide)

Owner Amylin Pharmaceuticals, Inc. incorporated in the State

Convention US 15 November 2007 77/331009

Service Spruson & Ferguson

Various Convention priority claimed: 15 November 2007, United States of America, No. 77/331009 in respect of PHARMACEUTICAL PREPARATIONS, NAMELY PHARMACEUTICAL PREPARATIONS FOR USE IN THE TREATMENT AND PREVENTION OF METABOLIC DISORDERS, ENDOCRINE CONDITIONS AND D

Filing Date 27 February 2008

Classes

Class 5 Pharmaceutical preparations, including pharmaceutical preparations for use in the treatment and prevention of metabolic disorders, endocrine conditions and disorders, diabetes, diabetic complications and hormonal diseases and disorders

Event Publications

20 March 2008 Application filed

17 April 2008 Application Accepted

14 August 2008 Trade Mark Registered/Protected

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.

Next and Previous Trademarks/Applications

1227015-TATACHILLA PARTNERS

1227013